PBAC's latest decision on Fentanyl, transdermal patch: Recommended with restriction (2006). Considered for chronic severe disabling pain not responding to non-narcotic analgesics.
PBAC outcome
Recommended with restriction
Restricted
ICER (AUD/QALY)
Cost-min
cost-minimisation analysis
Submissions
1
first 2006
Submissions
1
2006 → 2006
Eligible population
patients with non-cancer related pain
Therapy area
Pain
Line of therapy
Not applicable
Evidence base
RCT
Primary endpoint
Other
Key trials
Allan L et al (2001), Niemann T (2001), Allan L et al (2005)
Comparator
oral slow release morphine (OSRM)
Economic model
Cost-minimisation
ICER note
Cost-minimisation approach used; no ICER calculated